SEC Form 4 · accession 0001658613-17-000004
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Edward McKechnie
Director
Period of report
Sep 16, 2015
Accepted (ET)
Aug 28, 2017 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Aug 28, 2017 | A | 32,433 | $0.37 | A | 321,104 | D | |
| Common Shares | holding | — | — | — | 288,671 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $0.17 | holding | — | — | — | Sep 16, 2015 | Sep 16, 2020 | Common Shares | 110,000 | 110,000 | D |